ATAI Life Sciences N.V.’s recently made public that its insider Rao Srinivas unloaded Company’s shares for reported $0.11 million on Apr 02 ’24. In the deal valued at $1.85 per share,61,640 shares were sold. As a result of this transaction, Rao Srinivas now holds 113,360 shares worth roughly $0.24 million.
Then, Kirpekar Sahil sold 35,801 shares, generating $66,232 in total proceeds. Upon selling the shares at $1.85, the Chief Business Officer now owns 64,199 shares.
Before that, Johnson Anne Nagengast sold 27,410 shares. ATAI Life Sciences N.V. shares valued at $50,708 were divested by the Chief Financial Officer at a price of $1.85 per share. As a result of the transaction, Johnson Anne Nagengast now holds 73,590 shares, worth roughly $0.16 million.
Maxim Group upgraded its ATAI Life Sciences N.V. [ATAI] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Loop Capital’s analysts, who began to cover the stock in early November with a ‘”a Buy”‘ rating. Maxim Group began covering ATAI with “Buy” recommendation on November 30, 2021. ROTH Capital started covering the stock on November 11, 2021. It rated ATAI as “a Buy”.
Price Performance Review of ATAI
On Tuesday, ATAI Life Sciences N.V. [NASDAQ:ATAI] saw its stock jump 3.86% to $2.15. Over the last five days, the stock has lost -10.04%. ATAI Life Sciences N.V. shares have risen nearly 52.48% since the year began. Nevertheless, the stocks have risen 14.36% over the past one year. While a 52-week high of $2.85 was reached on 04/04/24, a 52-week low of $1.02 was recorded on 01/02/24. SMA at 50 days reached $1.96, while 200 days put it at $1.64. A total of 1.21 million shares were traded, compared to the trading of 1.63 million shares in the previous session.
Levels Of Support And Resistance For ATAI Stock
The 24-hour chart illustrates a support level at 2.06, which if violated will result in even more drops to 1.97. On the upside, there is a resistance level at 2.22. A further resistance level may holdings at 2.30. The Relative Strength Index (RSI) on the 14-day chart is 51.69, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.83%. Stochastics %K at 43.24% indicates the stock is a holding.
The most recent change occurred on October 18, 2021 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $40 price target.
